BASF Corporation is recalling 4,560 kilograms of Kollidon CL-M Crospovidone, a micronized inactive ingredient (excipient) used in manufacturing pharmaceutical products. This recall was initiated because the ingredient was found to be cross-contaminated with theophylline, a medication used to treat respiratory diseases. The affected batches were packaged in 30 kg plastic drums and distributed to pharmaceutical manufacturers nationwide and worldwide between November 2020 and present. Consumers should contact their healthcare provider if they suspect their medication was made using these contaminated materials.
The cross-contamination with theophylline poses a risk of unintended medication exposure, which can cause adverse reactions or drug interactions depending on the finished drug product it was used in. Theophylline has a narrow therapeutic range, meaning small amounts can significantly affect a patient's health or interfere with other medications.
You have 2 options:
Contact healthcare provider and return product
Manufacturer notification
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.